Home › Calculator › SGIOY Dividend Calculator 2026
SGIOY Dividend DRIP Calculator 2026
2.21% YieldHealthcareShionogi & Co., Ltd. · OTC
Price: $9.25 · Annual div: $0.20/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SGIOY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SGIOY snowball 📈
$10,000 in SGIOY → $9.05M in 10 years · $21,107.92/month
About Shionogi & Co., Ltd. (SGIOY) — Dividend Analysis 2026
Shionogi & Co., Ltd. operates as a Japanese pharmaceutical enterprise, dedicated to the discovery, creation, manufacturing, and commercialization of a diverse array of medicines, diagnostic reagents, and medical equipment within Japan. The firm markets several key therapeutic agents, including Fetroja, a crucial therapy for multi-drug resistant gram-negative bacterial infections; Xofluza, an antiviral medication for influenza; and Tivicay, an effective anti-HIV agent. Shionogi also maintains an extensive research and development pipeline, with numerous compounds under investigation for various conditions. Its development portfolio includes treatments for opioid-induced constipation (Symproic), various pain types such as inflammatory pain (S-120083), neuropathic pain (S-010887, sivopixant), and neuropathic low back pain (S-637880). Sivopixant is additionally being explored for sleep apnea syndrome and refractory/unexplained chronic cough. In neuroscience, the company is advancing S-117957 for insomnia, Zuranolone for depression, SDT-001 for attention-deficit/hyperactivity disorder, and BPN14770 for Fragile X syndrome and Alzheimer's disease. Furthermore, it is developing S-237648 and S-309309 as potential obesity treatments. In oncology and hepatology, ADR-001 addresses decompensated liver cirrhosis, and S-723595 targets NASH. Multiple anti-cancer compounds are in development, including S-588410 for esophageal and bladder cancer, S-488210 for head and neck squamous cell carcinoma, S-588210 and S-531011 for solid tumors, and S-222611 for malignant tumors. Other experimental therapies include S-770108 for idiopathic pulmonary fibrosis, SR-0379 for cutaneous ulcers, S-005151 for stroke and epidermolysis bullosa, and S-0373 for spinocerebellar ataxia. Addressing the ongoing pandemic, Shionogi is also advancing S-600918 and S-217622 for COVID-19, with S-555739 specifically aimed at preventing the aggravation of the disease. Beyond therapeutics, it supplies antibody test kits for COVID-19. The organization has established collaborative agreements with institutions like Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to further the development of antimalarial drugs. Founded in 1878, the company was initially known as Shionogi Shoten Co., Ltd. before adopting its current designation, Shionogi & Co., Ltd., in 1943. Its corporate operations are based in Osaka, Japan.
Compare SGIOY with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SGIOY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SGIOY position with:
🌍 SGIOY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SGIOY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.21% | -0.59% | $221 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.88% | -0.92% | $188 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.77% | -1.03% | $177 / yr |
| 🇬🇧 UK ISA | 0% | 2.21% | -0.59% | $221 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.02% | -0.78% | $202 / yr |
| 🇨🇦 TFSA | 0% | 2.21% | -0.59% | $221 / yr |
| 🇨🇦 CA Taxable | 25% | 1.66% | -1.14% | $166 / yr |
| 🇦🇺 Super (pension) | 15% | 1.88% | -0.92% | $188 / yr |
| 🇦🇺 AU Taxable | 30% | 1.55% | -1.25% | $155 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.63% | -1.17% | $163 / yr |
| 🇫🇷 FR Taxable | 30% | 1.55% | -1.25% | $155 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SGIOY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.20/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SGIOY Dividend Payment Schedule
SGIOY pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SGIOY vs Healthcare Benchmarks
How SGIOY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SGIOY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SGIOY Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SGIOY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Shionogi & Co., Ltd. (SGIOY) is currently trading at $9.25, 22% below its 52-week high. The current dividend yield is 2.21% based on an annual payout of $0.20 per share.
SGIOY (Shionogi & Co., Ltd.) — 2.21% Dividend Yield Analysis
Shionogi & Co., Ltd. (SGIOY) is a healthcare stock currently trading at $9.25 with a dividend yield of 2.21%. The company pays an annual dividend of $0.20 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SGIOY has grown its dividend at a compound annual rate of 97.8%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.